News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
131 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26478)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Generex Announces Upgrade to OTCQB Venture Market
The company announced that trading in its common stock will be upgraded to the OTCQB® Venture Market on November 30, 2017 after a successful application to up-list from the OTC Pink Market.
November 30, 2017
·
2 min read
Business
BioTelemetry Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
The study is expected to discover undiagnosed irregular heart rhythms, such as atrial fibrillation, using the Apple Watch and the dedicated “Apple Heart Study” App.
November 30, 2017
·
1 min read
Scythian Biosciences Completes Sale of Go Green
In addition to the cash compensation received, 27,000 common shares of Scythian are being returned to treasury for cancellation.
November 30, 2017
·
3 min read
Verona Pharma: PDMR Dealing
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
November 30, 2017
·
1 min read
Business
OraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV Testing
OraSure is working with The AIDS Institute to launch a grant program to encourage the development of innovative HIV self testing programs and collaborating with both The AIDS Institute and Walgreens to promote rapid HIV testing in cities across the U.S.
November 30, 2017
·
6 min read
ALK Secures Pricing and Reimbursement for ACARIZAX in France
A marketing authorisation for France was first granted in January 2016 and since then, ALK has been in dialogue with the authorities to secure market access for the product.
November 30, 2017
·
2 min read
BioCapital
Emergent BioSolutions to Host 2017 Analyst & Investor Day
This event, which is designed for sellside research analysts and institutional investors, will take place at The Westin New York at Times Square, 270 West 43rd Street, New York, New York 10036.
November 30, 2017
·
2 min read
BioCapital
K2M Announces Completion of 300 RHINE Cervical Disc System Surgical Cases
K2M to feature its RHINE Cervical Disc System, industry-leading 3D-printed portfolio, & Balance ACS® Platform at the 2017 Meeting of the German Spine Society.
November 30, 2017
·
10 min read
Business
Probiodrug Reports Third Quarter 2017 Business Update
The interim management report for the third quarter 2017 is available to download on the company’s website.
November 30, 2017
·
16 min read
Business
MorphoSys Signs Regional License Agreement for Antibody MOR202 With I-Mab
MorphoSys to receive a USD 20 million upfront payment and entitled to tiered, double digit royalties on net sales of MOR202 plus milestone payments of up to USD 100 million from I-Mab
November 30, 2017
·
6 min read
Previous
9 of 14
Next